Chemotherapy Overuse May Be Encouraged By Medicare AWP System - Tauzin
Executive Summary
The Medicare drug reimbursement system may be encouraging oncologists to overuse chemotherapy in terminal patients, House Commerce Committee Chairman Billy Tauzin (R-La.) asserted Sept. 21.
You may also be interested in...
PhRMA CEO Tauzin Takes Over Jan. 3: PR Focus Begins At The Top
PhRMA's new management team under CEO Billy Tauzin will place a high priority on communications and partnerships with other stakeholders in healthcare policy debates
Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents
The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market
Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents
The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market